Atenolol
Back to searchMolecule Structure
Scientific Name
Atenolol
Description of the Drug
Atenolol is a synthetic beta-1 selective blocker used in the management of hypertension and chronic angina, and to reduce mortality in known or suspected myocardial infarction in hemodynamically stable patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00335
http://www.drugbank.ca/drugs/DB00335
Brand Name(s)
Antipressan, Atenamin, Atenix-100, Atenix-25, Atenix-50, Atenolol, Ibinolo, Kentol, Tenormin, Tenormin 25, Tenormin l.s., Totamol, Unibloc, Vasaten
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Scs Pharmaceuticals, Zydus Pharmaceuticals Usa Inc, Novitium Pharma Llc, Able Laboratories Inc, Teva Pharmaceuticals Usa Inc, Healthcare Pharmaceuticals Ltd, Alvogen Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4362 | |
| PharmGKB | PA448499 | |
| Human Metabolome Database | HMDB0001924 | |
| DrugBank | DB00335 | |
| PubChem: Thomson Pharma | 14799140 | |
| PubChem | 2249 | |
| Mcule | MCULE-9148694071 | |
| NMRShiftDB | 20209081 | |
| LINCS | LSM-4355 | |
| Nikkaji | J3.170D | |
| BindingDB | 25753 | |
| EPA CompTox Dashboard | DTXSID2022628 | |
| DrugCentral | 255 | |
| Brenda | 62194 | |
| ChemicalBook | CB3753116 | |
| Guide to Pharmacology | 548 | |
| rxnorm | ATENOLOL | TENORMIN |
| PubChem: Drugs of the Future | 12014149 | |
| ChEBI | 2904 |
